T 0216/11 (Erythropoietin/EAST CAROLINA UNIVERSITY) of 14.11.2012
- European Case Law Identifier
- ECLI:EP:BA:2012:T021611.20121114
- Date of decision
- 14 November 2012
- Case number
- T 0216/11
- Online on
- 5 December 2012
- Petition for review of
- -
- Application number
- 02725577.7
- IPC class
- A61K 38/18A61K 45/00A61P 35/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
- Applicant name
- East Carolina University
- Opponent name
- BioGeneriX AG
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 108European Patent Convention R 101(1)
- Keywords
- Missing statement of grounds of appeal
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
ORDER
For these reasons it is decided that:
The appeal is rejected as inadmissible.